| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CEO and President | President and CEO +1 more
1 company
Patel Mahesh V. serves as a Chief Executive Officer at LPCN. Across recent SEC filings that breaks down to 21 buys and 4 sells. Those positions are worth an estimated $326K at current prices.
Historically, Patel Mahesh V.'s trades have earned a below-average insider score of 43/100 across 8 rated trades. Over a 12-month horizon, 14.3% of those trades were profitable, with an average 12-month return of -36.4%.
The biggest single holding is LPCN (~$326K) as Chief Executive Officer. Net of sales, the recent Form 4 record there shows accumulation of 544,706 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | LPCN Lipocine Inc. | Chief Executive Officer | Buy | 25,000 | $2.03 | $50,750.00 | +18.4% | +27.3% | - | |
| Apr 2, 2026 | LPCN Lipocine Inc. | Chief Executive Officer | Buy | 25,000 | $2.02 | $50,500.00 | +22.6% | +20.0% | - | |
| May 25, 2023 | LPCN Lipocine Inc. | CEO and President | Buy | 8,706 | $5.03 | $43,791.18 | +8.8% | -17.3% | +32.2% | |
| Mar 24, 2023 | LPCN Lipocine Inc. | CEO and President | Buy | 150,000 | $0.32 | $48,000.00 | +9.8% | -1.5% | -20.1% | |
| Mar 17, 2023 | LPCN Lipocine Inc. | CEO and President | Buy | 50,000 | $0.33 | $16,500.00 | +3.4% | -14.9% | -22.2% | |
| Nov 14, 2022 | LPCN Lipocine Inc. | CEO and President | Buy | 75,000 | $0.39 | $29,250.00 | +5.3% | +42.1% | -58.4% | |
| Sep 27, 2022 | LPCN Lipocine Inc. | CEO and President | Buy | 100,000 | $0.41 | $41,000.00 | +7.7% | +2.0% | -56.5% | |
| May 16, 2022 | LPCN Lipocine Inc. | CEO and President | Buy | 50,000 | $0.77 | $38,495.00 | +4.0% | -10.9% | -73.7% | |
| Nov 18, 2021 | LPCN Lipocine Inc. | CEO and President | Buy | 25,000 | $1.09 | $27,250.00 | +2.0% | +13.8% | -56.0% | |
| Dec 16, 2020 | LPCN Lipocine Inc. | Chief Executive Officer | Sale+OE | 15,000 | $1.35 | $20,250.00 | -1.2% | - | - |